
business
GlaxoSmithKline shuts down plant over legionnaires' bacteria
Pharmaceutical giant GlaxoSmithKline has shut down a US plant that produces inhaled medications after discovering the bacteria that causes Legionnaires’ disease.
A COMPREHENSIVE SERIES OF ARTICLES ON THIS TOPIC